Summary
- Current Price
- As of today, AMGN price is $442.36, up +4.02% on
- Current Price All-Time High
- AMGN price is currently -0.19% below its historical high of $443.19 set on
- Market Cap
- AMGN current market cap is $239B, up +50.42% over the past 365 days
- PE Ratio
- AMGN current PE ratio is 27.48
- Revenue
- AMGN current annual revenue is $36.74B, up +10.56% year-over-year
- Next Earnings
- The next earnings release for AMGN is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amgen Inc. |
| Ticker | NASDAQ: AMGN |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | General Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | |
| Website | amgen.com |
| Employees | 28,000 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $442.36 | |
| Price, 1D Change | +4.02% | |
| Market Cap | $239B | |
| TTM Dividend Yield | 2.22% | |
| PE Ratio | 27.48 | |
| Beta | 0.45 | |
| Revenue | $36.74B | |
| Revenue, 1Y Change | +10.56% | |
| EPS | $14.23 | |
| EPS, 1Y Change | +88.18% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.52 | |
| Next Ex-Dividend | $2.52 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| EPS | $14.23 | |
| EPS Estimate | $23.01 | N/A |
| EPS Est. Change | +61.71% | N/A |
| Revenue | $36.74B | |
| Revenue Estimate | $38.90B | N/A |
| Revenue Est. Change | +5.87% | N/A |
| Current Price | $442.36 | |
| Price Target | $388.00 | - |
| Price Tgt. Change | -12.29% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $19.60 | $7.56 | -61.43% | |
| $21.29 | $14.23 | -33.16% | |
| $23.01 | N/A | +61.71% | |
| $24.22 | N/A | +70.25% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $33.19B | $33.23B | +0.13% | |
| $36.34B | $36.74B | +1.11% | |
| $38.90B | N/A | +5.87% | |
| $39.94B | N/A | +8.70% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| Price, 1Y | +49.67% | |
| Price, 3Y | +68.96% | |
| Market Cap, 1Y | +50.42% | |
| Market Cap, 3Y | +70.88% | |
| Revenue, 1Y | +10.56% | |
| Revenue, 3Y | +40.81% | |
| EPS, 1Y | +88.18% | |
| EPS, 3Y | +17.47% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $442.36 | |
| SMA 200 | $351.44 | |
| SMA 50 | $375.14 | |
| EMA 200 | $350.80 | |
| EMA 50 | $382.68 | |
| MACD | $16.27 | |
| Beta | 0.45 | |
| ATR | $10.95 | |
| 14-Day RSI | 79.78 | |
| 10-Day Volatility | 22.89% |
Dividends
| Metric | Value | Date |
|---|---|---|
| Last Paid | $2.52 | |
| Upcoming | $2.52 | |
| Dividend Yield | 2.15% | |
| Total Dividend | $9.52 | |
| Dividends Paid | $5.12B | |
| Payout Ratio | 66.45% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| Revenue | $36.74B | |
| EPS | $14.23 | |
| Gross Profit | $30.33B | |
| Gross Margin | 70.80% | |
| Operating Income | $14.89B | |
| Operating Margin | 40.52% | |
| Net Income | $7.71B | |
| Net Margin | 20.98% | |
| EBITDA | $15.84B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| Debt To Equity | 6.31 | |
| Current Ratio | 1.14 | |
| Quick Ratio | 0.90 | |
| - | ||
| Piotroski F-Score | 8 | |
| Altman Z-Score | 2.36 |
Valuations
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| Book Value | $8.66B | |
| Cash & Equivalents | $9.13B | |
| Total Assets | $90.59B | |
| Current Assets | $29.06B | |
| Total Liabilities | $81.93B | |
| Current Liabilities | $25.49B | |
| Total Debt | $55.44B | |
| Short Term Debt | $4.73B | |
| Accounts Payable | $2.37B |
Expenses
| Metric | Value | Date |
|---|---|---|
| Total Expenses | $29.04B | |
| Operating Expenses | $15.44B | |
| Cost Of Goods Sold | $6.42B | |
| SG&A | $0.00 | |
| D&A | $5.17B | |
| Interest Expense | $0.00 | |
| Income Tax | $1.27B |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| CFO | $9.96B | |
| CFI | -$1.94B | |
| CFF | -$10.86B | |
| Capex | $1.86B | |
| Free Cash Flow | $8.10B |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Barclays | → | |
| Guggenheim | → | |
| Citigroup | → | |
| Bernstein | → | |
| Wells Fargo | → | |
| UBS | → | |
| Truist Securities | → | |
| TD Cowen | → | |
| Scotiabank | → | |
| RBC Capital | → |
Analyst sentiment
Institutional ownership
Screeners with AMGN
FAQ
- What is the ticker symbol for Amgen Inc.?
- The ticker symbol for Amgen Inc. is NASDAQ:AMGN
- Does Amgen Inc. pay dividends?
- Yes, Amgen Inc. pays dividends. The last payment was $2.52, with an ex-dividend date on May 15, 2026
- What sector is Amgen Inc. in?
- Amgen Inc. is in the Healthcare sector
- What industry is Amgen Inc. in?
- Amgen Inc. is in the General Drug Manufacturers industry
- What country is Amgen Inc. based in?
- Amgen Inc. is headquartered in United States
- When did Amgen Inc. go public?
- Amgen Inc. initial public offering (IPO) was on June 17, 1983
- Is Amgen Inc. in the S&P 500?
- Yes, Amgen Inc. is included in the S&P 500 index
- Is Amgen Inc. in the NASDAQ 100?
- Yes, Amgen Inc. is included in the NASDAQ 100 index
- Is Amgen Inc. in the Dow Jones?
- Yes, Amgen Inc. is included in the Dow Jones index
- When was Amgen Inc. last earnings report?
- Amgen Inc.'s most recent earnings report was on August 4, 2026
- When does Amgen Inc. report earnings?
- The next expected earnings date for Amgen Inc. is November 3, 2026
Data Sources & References
- AMGN Official Website www.amgen.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/318154/000031815426000003/0000318154-26-000003-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
- List of Dow Jones Industrial Average Companies en.wikipedia.org/wiki/Dow_Jones_Industrial_Average
- AMGN Profile on Yahoo Finance finance.yahoo.com/quote/AMGN
- AMGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amgn
